BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31559008)

  • 1. High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis.
    Sá-Sousa A; Almeida R; Vicente R; Nascimento N; Martins H; Freitas A; Fonseca JA
    Clin Transl Allergy; 2019; 9():47. PubMed ID: 31559008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
    Makhinova T; Barner JC; Richards KM; Rascati KL
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of excessive short-acting β
    Kupczyk M; Barg W; Bochenek G; Brożek G; D Browiecki P; Brzostek D; D Browski A; Dobek R; Gawlik R; Kucharczyk A; Kupryś-Lipińska I; Mastalerz-Migas A; Kowalski ML
    Postepy Dermatol Alergol; 2023 Dec; 40(6):790-797. PubMed ID: 38282873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in excessive oral corticosteroid exposure in poor adherent adult asthmatics overusing short-acting β-2 agonists.
    Sposato B; Petrucci E; Lacerenza GL; Micheletto C; Montagnani A; Alessandri M; Cresti A; Serafini A; Lena F; Scala R; Rogliani P; Perrella A; Scalese M
    Minerva Med; 2023 Oct; 114(5):642-651. PubMed ID: 34269554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Short-Acting β
    Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E;
    Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
    Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W
    J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids.
    Elkout H; McLay JS; Simpson CR; Helms PJ
    Arch Dis Child; 2010 Oct; 95(10):817-21. PubMed ID: 20656730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.
    Wong MD; Manley RT; Stettin G; Chen W; Salmun LM
    Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population.
    Fung LW; Yan VK; Kwan C; Kwok WC; Lam DC; McDonald CF; Bloom CI; Wong IC; Chan EW
    BMC Pulm Med; 2024 May; 24(1):232. PubMed ID: 38745268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed.
    van der Meer AN; de Jong K; Ferns M; Widrich C; Ten Brinke A
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2093-2098. PubMed ID: 35405380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia.
    Hew M; McDonald VM; Bardin PG; Chung LP; Farah CS; Barnard A; Cooper MS; Gibson PG; Upham JW
    Med J Aust; 2020 Oct; 213(7):316-320. PubMed ID: 32906192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
    J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children.
    Elkout H; Helms PJ; Simpson CR; McLay JS
    PLoS One; 2012; 7(6):e39130. PubMed ID: 22761728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma.
    Butz AM; Thompson RE; Tsoukleris MG; Donithan M; Hsu VD; Mudd K; Zuckerman IH; Bollinger ME
    J Asthma; 2008 Nov; 45(9):800-6. PubMed ID: 18972299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma.
    Heatley H; Tran TN; Bourdin A; Menzies-Gow A; Jackson DJ; Maslova E; Chapaneri J; Skinner D; Carter V; Chan JSK; Ariti C; Haughney J; Price DB
    Thorax; 2023 Sep; 78(9):860-867. PubMed ID: 36575040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-prescription of short-acting β
    Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI
    Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs associated with short-acting β
    Attar-Zadeh D; Capstick T; Leese D; Arnetorp S; Rapsomaniki E; Da Costa KP; Maslova E; Xu Y; Gibson D; Quint JK
    BJGP Open; 2023 Sep; 7(3):. PubMed ID: 36759020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-prescription of short-acting β
    Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M
    Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F
    Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.